Peer review reports
From: Toceranib phosphate (Palladia) for the treatment of canine exocrine pancreatic adenocarcinoma
Original Submission | ||
---|---|---|
25 Feb 2021 | Submitted | Original manuscript |
19 Mar 2021 | Reviewed | Reviewer Report |
1 Apr 2021 | Reviewed | Reviewer Report - Charles H C Halsey |
21 Apr 2021 | Author responded | Author comments - Margaret L. Musser |
Resubmission - Version 2 | ||
21 Apr 2021 | Submitted | Manuscript version 2 |
23 Apr 2021 | Reviewed | Reviewer Report |
5 May 2021 | Reviewed | Reviewer Report - Charles H C Halsey |
16 May 2021 | Author responded | Author comments - Margaret L. Musser |
Resubmission - Version 3 | ||
16 May 2021 | Submitted | Manuscript version 3 |
25 May 2021 | Reviewed | Reviewer Report |
27 May 2021 | Author responded | Author comments - Margaret L. Musser |
Resubmission - Version 4 | ||
27 May 2021 | Submitted | Manuscript version 4 |
21 Jun 2021 | Reviewed | Reviewer Report |
Resubmission - Version 5 | ||
Submitted | Manuscript version 5 | |
Publishing | ||
20 Jul 2021 | Editorially accepted | |
11 Aug 2021 | Article published | 10.1186/s12917-021-02978-8 |